Entecavir add-on Peg-interferon therapy plays a positive role in reversing hepatic fibrosis in treatment-naïve chronic hepatitis B patients: a prospective and randomized controlled trial

Entecavir add-on Peg-interferon therapy plays a positive role in reversing hepatic fibrosis in treatment-naïve chronic hepatitis B patients: a prospective and randomized controlled trial

Abstract. Background. The efficacy of entecavir (ETV) add-on peg-interferon therapy compared with ETV monotherapy in treatment-naïve hepatitis B virus (HBV) patients remains controversial. We investigated whether adding peg-interferon to ongoing ETV treatment leads to a better curative effect or not...

Full description

Bibliographic Details
Main Authors: Jing-Mao Yang, Li-Ping Chen, Ya-Jie Wang, Bei Lyu, Hong Zhao, Zhi-Yin Shang, Jun Li, Zhen-Yu Fan, Sheng-Di Wu, Xiao Ming, Xian Li, Shao-Ping Huang, Ji-Lin Cheng, Yuan-Yuan Ji
Format: Article
Language:English
Published: Wolters Kluwer 2020-07-01
Series:Chinese Medical Journal
Online Access:http://journals.lww.com/10.1097/CM9.0000000000000857

Internet

http://journals.lww.com/10.1097/CM9.0000000000000857

Similar Items